| 1 |
Circular regarding attending office during Parliament Session |
2021-Aug-03 |
|
1880 KB |
| 2 |
Data for Income Tax Calculation for the Financial Year 2021-22 |
2021-Aug-02 |
|
3990 KB |
| 3 |
Clarification if change in a) Polymorphs/crystalline/amorphous/solvates/hydrate etc (b) salt and (c) Derivative/analogue/ester etc of already approved active substance to be considered as new drug if main active moiety (Active Pharmaceutical Ingredient-API) is same? |
2021-Jul-23 |
|
131 KB |
| 4 |
Consolidated Instructions for Global Tender Enquiry (GTE) under Rule 161(iv) of General Financial Rules (GFRs), 2017 |
2021-Jul-07 |
|
3372 KB |
| 5 |
Circular regarding attending office regularly dated 07.07.2021 |
2021-Jul-07 |
|
602 KB |
| 6 |
Reconstituting of Internal Complaint Committee on sexual Harassment cases regarding 25 june 2021 |
2021-Jun-25 |
|
920 KB |
| 7 |
Special Condition under which the permission for import of drug with residual shelf life less than 60% is allowed |
2021-Apr-13 |
|
373 KB |
| 8 |
RT-PCR Test for COVID-19 of the staff of CDSCO at FDA bhawan |
2021-Apr-07 |
|
908 KB |
| 9 |
Declaration of Holiday on 14th April 2021 Dr. B R Ambedkar |
2021-Mar-31 |
|
334 KB |
| 10 |
Office Meorandum regarding for pusuing higher qualification |
2021-Mar-26 |
|
735 KB |
